ClinVar Miner

Submissions for variant NM_001370658.1(BTD):c.1207T>C (p.Cys403Arg)

gnomAD frequency: 0.00001  dbSNP: rs397514412
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000021998 SCV000942909 pathogenic Biotinidase deficiency 2023-06-30 criteria provided, single submitter clinical testing This variant is present in population databases (rs397514412, gnomAD 0.007%). This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 423 of the BTD protein (p.Cys423Arg). This missense change has been observed in individual(s) with biotinidase deficiency (PMID: 9396567, 27657684, 31035122). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 25073). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTD protein function. For these reasons, this variant has been classified as Pathogenic.
Revvity Omics, Revvity RCV000021998 SCV002022098 likely pathogenic Biotinidase deficiency 2023-07-14 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV002477004 SCV002047132 likely pathogenic not provided 2021-05-20 criteria provided, single submitter clinical testing The variant occurs in multiple cases with a lone recessive pathogenic/likely pathogenic variant in the same gene, and several have phenotype known to be consistent with disease. The variant predicted to have a damaging effect on the protein and is damaging to protein function(s) relevant to disease mechanism.
Myriad Genetics, Inc. RCV000021998 SCV002060304 uncertain significance Biotinidase deficiency 2021-11-19 criteria provided, single submitter clinical testing NM_000060.2(BTD):c.1267T>C(C423R) is a missense variant classified as a variant of uncertain significance in the context of biotinidase deficiency. C423R has been observed in cases with relevant disease (PMID: 10400129, 9396567, 31035122). Functional assessments of this variant are not available in the literature. C423R has been observed in population frequency databases (gnomAD: NFE 0.01%). In summary, there is insufficient evidence to classify NM_000060.2(BTD):c.1267T>C(C423R) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening.
Baylor Genetics RCV000021998 SCV004211438 pathogenic Biotinidase deficiency 2023-08-03 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000021998 SCV004223513 pathogenic Biotinidase deficiency 2023-11-08 criteria provided, single submitter clinical testing Variant summary: BTD c.1207T>C (p.Cys403Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251372 control chromosomes. c.1207T>C, described as p.Cys423Arg, has been reported at a compound heterozygous state along with different apparently pathogenic variants in at-least four individuals affected with Biotinidase Deficiency (examples, Forny_2022, Iseghem_2019, Pomponio_1997, Wolf_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 35195902, 31035122, 9396567, 27657684). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 (PATH, n=1, Likely pathogenic, n=2, VUS, n=1). Based on the evidence outlined above, the variant was classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.